Co-Diagnostics (C970) Ratios
Co-Diagnostics Ratios
DE:C970's free cash flow for Q2 2026 was $-7.17M. For the 2026 fiscal year, DE:C970's free cash flow was decreased by $-18.28K and operating cash flow was $-7.15M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.87 | 4.41 | 10.81 | 23.94 | 9.14 |
| Quick Ratio | 3.59 | 4.27 | 10.52 | 22.57 | 8.98 |
| Cash Ratio | 3.36 | 0.40 | 2.60 | 5.93 | 7.03 |
| Solvency Ratio | -11.13 | -3.74 | -3.66 | -1.51 | 1.45 |
| Operating Cash Flow Ratio | -8.23 | -3.99 | -3.84 | 1.70 | 3.26 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 9.58M | $ 22.60M | $ 52.83M | $ 84.17M | $ 89.56M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.03 | 0.03 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.06 | 0.04 | 0.03 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.06 | 0.04 | 0.03 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.20 | 1.18 | 1.11 | 1.07 | 1.19 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.93 | 2.13 | 3.06 | 0.33 | 0.00 |
| Net Debt to EBITDA | 0.22 | 0.02 | 0.29 | 2.19 | -1.91 |
| Profitability Margins | |||||
| Gross Profit Margin | 64.28% | 74.48% | 38.57% | 83.98% | 88.18% |
| EBIT Margin | -7793.22% | -959.90% | -626.92% | -33.87% | 47.06% |
| EBITDA Margin | -7615.41% | -924.72% | -608.86% | -30.13% | 47.40% |
| Operating Profit Margin | -5025.53% | -1023.75% | -626.92% | -78.85% | 47.06% |
| Pretax Profit Margin | -7793.22% | -959.90% | -559.46% | -55.08% | 46.62% |
| Net Profit Margin | -7533.62% | -961.37% | -518.68% | -41.61% | 37.45% |
| Continuous Operations Profit Margin | -7533.62% | -961.37% | -518.68% | -41.61% | 37.45% |
| Net Income Per EBT | 96.67% | 100.15% | 92.71% | 75.55% | 80.33% |
| EBT Per EBIT | 155.07% | 93.76% | 89.24% | 69.86% | 99.07% |
| Return on Assets (ROA) | -189.54% | -58.81% | -37.07% | -11.57% | 22.91% |
| Return on Equity (ROE) | -227.33% | -69.30% | -41.08% | -12.43% | 27.26% |
| Return on Capital Employed (ROCE) | -147.54% | -70.71% | -47.68% | -22.63% | 31.24% |
| Return on Invested Capital (ROIC) | -138.31% | -69.59% | -43.79% | -17.05% | 25.10% |
| Return on Tangible Assets | -267.62% | -99.31% | -51.27% | -14.78% | 31.03% |
| Earnings Yield | -695.36% | -165.44% | -90.53% | -17.95% | 14.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.27 | 29.53 | 20.59 | 6.34 | 4.68 |
| Payables Turnover | 0.12 | 0.30 | 2.82 | 5.76 | 19.05 |
| Inventory Turnover | 0.22 | 0.93 | 2.51 | 1.03 | 5.78 |
| Fixed Asset Turnover | 0.18 | 0.80 | 1.13 | 11.75 | 50.63 |
| Asset Turnover | 0.03 | 0.06 | 0.07 | 0.28 | 0.61 |
| Working Capital Turnover Ratio | 0.04 | 0.10 | 0.09 | 0.36 | 1.17 |
| Cash Conversion Cycle | -1342.33 | -799.21 | 33.66 | 347.81 | 122.03 |
| Days of Sales Outstanding | 111.63 | 12.36 | 17.73 | 57.59 | 77.99 |
| Days of Inventory Outstanding | 1628.88 | 391.89 | 145.19 | 353.64 | 63.20 |
| Days of Payables Outstanding | 3082.84 | 1203.46 | 129.27 | 63.42 | 19.16 |
| Operating Cycle | 1740.51 | 404.25 | 162.92 | 411.23 | 141.18 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -21.90 | -28.83 | -22.57 | 6.26 | 42.68 |
| Free Cash Flow Per Share | -22.43 | -29.57 | -23.97 | 4.90 | 41.99 |
| Dividend Paid and CapEx Coverage Ratio | -41.62 | -38.96 | -16.17 | 4.60 | 61.36 |
| Capital Expenditure Coverage Ratio | -41.62 | -38.96 | -16.17 | 4.60 | 61.36 |
| Operating Cash Flow Coverage Ratio | -23.56 | -13.55 | -7.38 | 18.88 | 0.00 |
| Operating Cash Flow to Sales Ratio | -46.81 | -7.45 | -3.24 | 0.19 | 0.42 |
| Free Cash Flow Yield | -442.42% | -131.43% | -60.07% | 6.48% | 15.67% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.14 | -0.60 | -1.10 | -5.57 | 7.03 |
| Price-to-Sales (P/S) Ratio | 10.83 | 5.81 | 5.73 | 2.32 | 2.63 |
| Price-to-Book (P/B) Ratio | 0.33 | 0.42 | 0.45 | 0.69 | 1.92 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.23 | -0.76 | -1.66 | 15.43 | 6.38 |
| Price-to-Operating Cash Flow Ratio | -0.23 | -0.78 | -1.77 | 12.08 | 6.28 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | -0.18 | -0.01 | 0.04 | 0.00 |
| Enterprise Value Multiple | 0.08 | -0.61 | -0.65 | -5.50 | 3.65 |
| Enterprise Value | -3.90M | 21.97M | 27.10M | 56.70M | 169.24M |
| EV to EBITDA | 0.08 | -0.61 | -0.65 | -5.50 | 3.65 |
| EV to Sales | -6.27 | 5.61 | 3.98 | 1.66 | 1.73 |
| EV to Free Cash Flow | 0.13 | -0.73 | -1.16 | 11.03 | 4.19 |
| EV to Operating Cash Flow | 0.13 | -0.75 | -1.23 | 8.63 | 4.12 |
| Tangible Book Value Per Share | 10.08 | 27.90 | 60.94 | 83.63 | 96.18 |
| Shareholders’ Equity Per Share | 15.51 | 53.71 | 87.93 | 109.14 | 139.72 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.03 | -0.00 | 0.07 | 0.24 | 0.20 |
| Revenue Per Share | 0.47 | 3.87 | 6.96 | 32.61 | 101.70 |
| Net Income Per Share | -35.25 | -37.22 | -36.12 | -13.57 | 38.09 |
| Tax Burden | 0.97 | 1.00 | 0.93 | 0.76 | 0.80 |
| Interest Burden | 1.00 | 1.00 | 0.89 | 1.63 | 0.99 |
| Research & Development to Revenue | 30.74 | 5.36 | 3.37 | 0.51 | 0.15 |
| SG&A to Revenue | 18.38 | 5.27 | 2.10 | 0.42 | 0.12 |
| Stock-Based Compensation to Revenue | 3.61 | 1.39 | 1.22 | 0.22 | 0.06 |
| Income Quality | 0.62 | 0.77 | 0.62 | -0.46 | 1.12 |
Currency in USD